SMART planning Gastrointestinal November 1, 2022 The first large prospective study of 136 patients across 13 institutions receiving SMART for pancreatic cancer achieved local control in…
Notable Gastrointestinal June 7, 2022 The outcomes of the Chinese phase 3 NOTABLE trial that demonstrated across 92 patients with KRAS-wildtype unresectable and/or metastatic pancreatic…
Tough target Gastrointestinal June 3, 2022 This case report describes an exciting (although n=1) response to T-cell receptor gene therapy in a patient with refractory, metastatic…
